Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Videos | Radiation Therapy
VIDEO: Use of Radiation Therapy as a Bridge-to-transplant in Liver Cancer

Nima Nabavizadeh, M.D., radiation oncologist and associate professor of radiation medicine, Oregon Health and Science ...

Time February 02, 2022
arrow
Videos | Radiation Oncology
VIDEO: How to Manage the Complex Needs of Pelvic Radiotherapy Patients

Bridget F. Koontz, M.D., chief medical officer at GenesisCare USA explains how to manage the complex needs of pelvic ...

Time February 02, 2022
arrow
Videos | Radiation Oncology
VIDEO: 3-D Virtual Reality Aids Patient Understanding of Their Cancer and Therapy

Douglas E. Holt, M.D., a radiation oncologist at Eastern Idaho Regional Medical Center, explains the use of 3-D virtual ...

Time February 02, 2022
arrow
The Petten High Flux Reactor in Petten, Netherlands. Image by Tetzemann - Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=83953498
News | Nuclear Imaging
Update on Unplanned Outage of the HFR Reactor

February 2, 2022 — Nuclear Medicine Europe has announced that the HFR reactor in Petten, Netherlands, did not resume ...

Time February 02, 2022
arrow
The global medical radiation detection market was valued at $1,173.0 million in 2020 and is projected to reach $2,558.1 million by 2030, registering a CAGR of 8.4% from 2021 to 2030, according to the new report, "Medical Radiation Detection Market by Detection Type, Product, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" from ResearchAndMarkets.com.
News | Nuclear Imaging
Growing Use of Nuclear Medicine and Radiation Therapy for Diagnosis and Treatment

January 31, 2022 — The global medical radiation detection market was valued at $1,173.0 million in 2020 and is projected ...

Time January 31, 2022
arrow
TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the world’s very first 6 MeV Proton Cyclotron, operating in excess of 500 micro amp current, to a National Lab today.
News | Molecular Imaging
Shipment of World’s Very First 6 MeV Proton Cyclotron

January 28, 2022 — TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the ...

Time January 28, 2022
arrow
UVA Cancer Center's David Schiff, MD, co-chaired a blue-ribbon panel that developed important new guidelines for treating brain metastases — cancers that have spread to the brain. Image courtesy of UVA Health
News | Radiation Oncology
New Brain Cancer Guidelines to Improve Care, Patient Survival

January 27, 2022 — New guidelines for treating cancers that have spread to the brain are poised to improve care for ...

Time January 27, 2022
arrow
On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks.
News | Nuclear Imaging
SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply

January 26, 2022 — On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that ...

Time January 26, 2022
arrow
For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used prostate cancer patients’ DNA to create a model that appears to predict who will have side effects from radiation.   
News | Prostate Cancer
Genetics Predicts Toxic Side Effects to Prostate Cancer Radiotherapy

January 19, 2022 — For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used ...

Time January 19, 2022
arrow
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation therapy to treat adult patients with primary liver cancers using external beam radiation therapy (EBRT).
News | Radiation Therapy
ASTRO Issues Clinical Guideline on External Beam Radiation Therapy for Primary Liver Cancers

January 13, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time January 13, 2022
arrow
Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that the first patient has been enrolled in NANORAY-312, a global, open-label, two-arm, randomized, Investigator’s Choice phase III registration study that is designed to investigate the efficacy and safety of radiotherapy-activated NBTXR3 with or without cetuximab versus radiotherapy with or without cetuximab in high-risk, chemotherapy-ineli
News | Radiation Therapy
First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer

January 10, 2022 — Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time January 10, 2022
arrow
News | Radiation Oncology
Helping Cancer Patients Avoid Excessive Radiation

January 7, 2022 — A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to ...

Time January 07, 2022
arrow
IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announced a new contract for the installation of a Proteus ONE[1] proton therapy solution with Proton International Arkansas LLC – a joint venture formed by Proton International, the University of Arkansas for Medical Sciences (UAMS), Baptist Health, and Arkansas Children’s.
News | Proton Therapy
IBA and Proton International Sign Contract for Proteus ONE Proton Therapy Solution in Arkansas

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the opening of its INDux training center to maximize talent, share experiences and optimize knowledge of both customers and employees at its headquarters in Louvain-La-Neuve, Belgium.
News | Radiation Oncology
IBA Launches INDux Training Center to Optimize Customer Performance

December 30, 2021 — IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the ...

Time December 30, 2021
arrow
Role of P3HT MW and polyimide substrate thickness on the functionality of curved X-ray detectors. Loading and unloading P–h curves for the a) NP-BHJ films containing different P3HT MW and b) polyimide substrates of different thicknesses. Misfit strain as a function of both radius of curvature and substrate thickness for NP-BHJ film based on c) P3HT A and d) P3HT D. Misfit strain between the film and substrate increases when thinner substrates and lower P3HT MW are used. Photograph indicating the tendency of
News | Radiation Therapy
Safer X-rays and Radiation Therapy a Step Closer Thanks to Surrey Research

December 29, 2021 — Researchers at the University of Surrey have identified key design rules for making curved X-ray ...

Time December 29, 2021
arrow
Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021.
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in December 2021

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
Neurosurgeon Adam Robin, M.D., surgically implants a GammaTile device for the first time in Michigan. Image courtesy of Henry Ford Health System
News | Radiation Therapy
Henry Ford Health System First in Michigan to Implant Novel Therapy for Recurrent Brain Tumors

December 22, 2021 — Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor by ...

Time December 22, 2021
arrow
 IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA.
News | Proton Therapy
IBA and New Mexico Cancer Center Sign Contract to Install a Proteus ONE

December 22, 2021 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s ...

Time December 22, 2021
arrow
RayCare 5B features full user configurability of all workflow configuration settings, including the possibility to create advanced workflow automation, from the administrator’s workspace.
News | Radiation Oncology
RayCare 5B Provides Cancer Clinics with User Configurable Workflows for Radiation Therapy

December 22, 2021 — RayCare 5B features full user configurability of all workflow configuration settings, including the ...

Time December 22, 2021
arrow
Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it is now recruiting patients for a phase 1 study of its X-PACT Cancer Treatment system in Breast, Melanoma, Sarcoma and Head and Neck Cancers, to be conducted at Duke University Medical Center.
News | Radiation Oncology
Immunolight, LLC Now Recruiting Patients for Phase 1 Trial of the X-PACT System in Solid Tumors

December 20, 2021 — Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies ...

Time December 20, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now